Roche
ROG.SW
$271.54
Share price
-0.96%
Change (1 day)
-16.91%
Change (1 year)
Categories
Roche (ROG.SW) - Total assets
Total assets on the balance sheet as of December 2022 : $95.42 B
According to Roche's latest financial reports the company's total assets are $95.42 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Roche - Total assets on balance sheet (from 2006 to 2022)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2022-12-31 | $95.42 B | -5.56% |
| 2021-12-31 | $101.03 B | 3.41% |
| 2020-12-31 | $97.70 B | 13.9% |
| 2019-12-31 | $85.78 B | 7.46% |
| 2018-12-31 | $79.82 B | 1.37% |
| 2017-12-31 | $78.74 B | 4.42% |
| 2016-12-31 | $75.40 B | -1.66% |
| 2015-12-31 | $76.68 B | 0.22% |
| 2014-12-31 | $76.51 B | 9.2% |
| 2013-12-31 | $70.07 B | -1.32% |
| 2012-12-31 | $71.01 B | 8.18% |
| 2011-12-31 | $65.63 B | 0.52% |
| 2010-12-31 | $65.29 B | -9.43% |
| 2009-12-31 | $72.09 B | -1.18% |
| 2008-12-31 | $72.95 B | 5.64% |
| 2007-12-31 | $69.06 B | 12.92% |
| 2006-12-31 | $61.16 B | 16.03% |
| 2005-12-31 | $52.71 B | 3.53% |
| 2004-12-31 | $50.92 B | 5.86% |
| 2003-12-31 | $48.10 B | -33.96% |
| 2002-12-31 | $72.84 B | -15% |
| 2001-12-31 | $85.69 B |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $195.96 B | 105.37% | 🇺🇸 USA |
 Novartis NVS | $110.97 B | 16.30% | 🇨🇭 Switzerland |
 Pfizer PFE | $195.61 B | 105.00% | 🇺🇸 USA |
 Abbott Laboratories ABT | $73.79 B | -22.67% | 🇺🇸 USA |
 Amgen AMGN | $90.26 B | -5.40% | 🇺🇸 USA |
 Sanofi SNY | $136.23 B | 42.77% | 🇫🇷 France |
 Becton Dickinson BDX | $53.01 B | -44.44% | 🇺🇸 USA |
 Merck MRK | $107.79 B | 12.97% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $75.00 B | -21.39% | 🇬🇧 UK |